Xpovio Receives Accelerated Approval for Diffuse Large B-Cell LymphomaThe U.S. Food and Drug Administration (FDA) has approved Xpovio for the treatment of diffuse large B-cell lymphoma. Xpovio (selinexor) is for adults with refractory or relapsed diffuse large B-cell... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
Tazverik Receives Accelerated Approval for Follicular LymphomaThe United States Food and Drug Administration (US FDA) has approved Tazverik for use in relapsed or refractory (R/R) follicular lymphoma. Tazverik (tazemetostat) is for adults with a mutation in... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
COVID-19 Updates, June 15: Solidarity Hydroxychloroquine Trials and COVID Vaccine DevelopmentMany of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments... By Editorial TeamBookmark for later Reactions 0 reactions Comments3 comments
COVID-19 Updates, May 7: Remdesivir, Antibody Testing, and Reinfection RiskOur world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Darzalex Faspro For Multiple MyelomaThe United States Food and Drug Administration (US FDA) has approved Darzalex Faspro for the treatment of newly diagnosed or relapsed/refractory multiple myeloma. Darzalex Faspro (a combination of the drugs... By Editorial TeamBookmark for later Reactions 0 reactions Comments0 comments
FDA Approves Ibrutinib plus Rituximab for Chronic Lymphocytic LeukemiaThe U.S. Food and Drug Administration (FDA) has granted approval to the Janssen Pharmaceutical Companies of Johnson & Johnson to expand the indications for Imbruvica® (ibrutinib) to be used in... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
FDA Approves Reblozyl for Anemia Associated with MDSThe United States Food and Drug Administration (US FDA) has approved the use of Reblozyl® for anemia related to some myelodysplastic syndromes (MDS). When a person has anemia, they have... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
COVID-19 Updates, April 7: Face Coverings, Testing, & MedicationsIt is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
What to Know About Cancer and COVID-19 (Coronavirus)The spread of the novel coronavirus, COVID-19, has changed our daily lives. But people with a higher risk for illness from COVID-19 are wondering what they can do to stay... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
Take the Fatigue and Health Survey!The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic... By Editorial TeamBookmark for later Reactions 0 reactions Comments2 comments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
COVID-19: Tips To Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to... By Editorial TeamBookmark for later Reactions 0 reactions Comments2 comments
COVID-19: Basics for the Immune-CompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can... By Editorial TeamBookmark for later Reactions 0 reactions Comments4 comments
FDA Approves Sarclisa® for Previously Treated Multiple MyelomaThe U.S. Food and Drug Administration (FDA) has granted approval to Sanofi-Aventis U.S. LLC for Sarclisa® (isatuximab-irfc), to be used in combination with pomalidomide and dexamethasone for the treatment of... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
The American Cancer Society Issues 2020 Report on CancerThe American Cancer Society (ACS) recently released its report, Cancer Statistics, 2020. The report found that the death rate from cancer in the US is dropping. Between 1991 and 2017... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
FDA Approves Calquence for CLL and SLLThe drug acalabrutinib (Calquence®) was recently approved to treat 2 more types of blood cancer in adults: chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). It had already been... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
FDA Approves Brukinsa for Treatment of Mantle Cell LymphomaRecently, the U.S. Food and Drug Administration (FDA) approved BrukinsaTM (zanubrutinib) to treat mantle cell lymphoma. Mantle cell lymphoma is a rare type of non-Hodgkin lymphoma (NHL), a blood cancer... By Editorial TeamBookmark for later Reactions 0 reactions Comments1 comments
FDA Approves Darzalex Combination for Newly Diagnosed, Stem Cell Transplant-Eligible Multiple MyelomaThis past week, the United States Food and Drug Administration (U.S. FDA) approved the monoclonal antibody daratumumab (Darzalex) for the treatment of adults with newly diagnosed multiple myeloma who are... By Editorial TeamBookmark for later Reactions 0 reactions Comments2 comments
Take the Chronic Pain In America Survey! (Now Closed)We know the frustrations of chronic pain. Will you help others understand by taking our survey? Simply put, living with chronic pain is painful. But there is so much more... By Editorial TeamBookmark for later Reactions 0 reactions Comments2 comments
New Study Shows Family History of Blood Cancer Increases RiskAlthough the risks for developing blood cancer are still being researched and not fully known or understood, there may be a genetic component to it. A combination of genetic and... By Editorial TeamBookmark for later Reactions 0 reactions Comments3 comments
